support@mellalta.com   +1 (304) 306-0723

Actinium’s Multi-billion Dollar Market for Targeted Conditioning with their revolutionary Antibody Warhead Enabling (AWE) platform!

Actinium Pharmaceuticals’ Antibody Warhead Enabling (AWE) Future Opportunities

Actinium Pharmaceuticals is a clinical stage biopharmaceutical company, with an impressive Antibody Warhead Enabling (AWE) technology. The technology enables the development of breakthrough Antibody Radiation-Conjugates (ARCs), that combine the targeting ability of antibodies with the […]

Read More

Get In Touch

Let's keep the conversation going